Cancer Vaccine Passes First Human Trial With Zero Toxicity

A new cancer vaccine showed promising safety and immune response in 36 patients with advanced lung, ovarian, and prostate cancer.

The treatment caused only minor injection-site reactions while triggering strong immune responses.